Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

QUZYTTIR

CETIRIZINE HYDROCHLORIDE

Standard Dose
10MG/ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview QUZYTTIR is listed in Drugs@FDA under application 211415 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CETIRIZINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 10MG/ML (10MG/ML) Sponsor JDP Submission history Latest submission status date: 2025-07-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview QUZYTTIR is listed in Drugs@FDA under application 211415 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CETIRIZINE HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 10MG/ML (10MG/ML) Sponsor JDP Submission history Latest submission status date: 2025-07-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.